SROI is a widely used approach to monetise impact that helps to quantify societal benefits of an intervention. For veonet, it shows the net benefit to society that each of our cataract surgeries creates as a factor of societal cost of the intervention. Veonet's first-eye cataract surgery generates an average SROI of 73x over the average life expectancy after time of surgery.
Generating lasting social value through veonet’s cataract surgeries by enhancing patients’ quality of life, reducing burden on caregivers, and lowering risk of accident & emergency (A&E) care need
Posterior Capsular Rupture (PCR), a complication that can occur during cataract surgery, typically affects 1–2% of procedures industry-wide. Our average rate of just 0.45% demonstrates a high standard and reflects our commitment to surgical excellence and patient safety.
Lead on medical quality, using integrated platform to deliver excellent clinical outcomes across geographies
In healthcare, the Net Promoter Score (NPS), a measure of patient satisfaction and loyalty, any score above 50 is considered as excellent, making our score of 75 a strong indicator of exceptional patient experience.
Leverage experience, scale and new technologies to deliver the best patient experience
We invest in our people. With over 6,000 team members, we are home to many of Europe’s leading ophthalmologists and clinical professionals. We have been recognised as a Great Place to Work across all our territories, and we support our teams with the tools, autonomy, and environment they need to thrive. Because great outcomes start with great people.
Attract and retain the best talent, favoured by doctors and clinical staff alike
With an average Scope 1+2 emissions intensity of 6.2 tonnes of CO₂ equivalent per million euros of revenue (tCO₂e/€m), this benchmark helps guide our targeted efforts to reduce carbon emissions, energy use, and waste as part of our broader sustainability commitment.
Reduce carbon emissions, energy consumption, and waste across the Group
With 97% of employees trained on the Code of Conduct, veonet reinforces a culture of integrity and the highest standards. Group medical governance is guided by the veonet Medical Board, a group of leading ophthalmologists from across Europe that ensures clinical excellence, drives quality, and enhances patient outcomes through collaboration, innovation, and a unified clinical strategy.
Maintain highest standards of governance and compliance across the Group
veonet creates significant social value with its cataract surgeries, yielding a Social Return on Investment of 73x